# Pilot Study of Taxol, Carboplatin, and Bevacizumab in Advanced Stage Ovarian Carcinoma Patients

> **NCT00127920** · PHASE2 · COMPLETED · sponsor: **Gynecologic Oncology Associates** · enrollment: 20 (actual)

## Conditions studied

- Ovarian Neoplasms

## Interventions

- **DRUG:** Avastin

## Key facts

- **NCT ID:** NCT00127920
- **Lead sponsor:** Gynecologic Oncology Associates
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-08
- **Primary completion:** 2006-08
- **Final completion:** 2012-10
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2015-03-10

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00127920

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00127920, "Pilot Study of Taxol, Carboplatin, and Bevacizumab in Advanced Stage Ovarian Carcinoma Patients". Retrieved via AI Analytics 2026-09-07 from https://api.ai-analytics.org/clinical/NCT00127920. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*